The shares of Fate Therapeutics, Inc. (NASDAQ:FATE) started off the last trading session with the price of $13.31 while closing the day with the price of $13.06. The shares of Fate Therapeutics, Inc. (NASDAQ:FATE) Fell -0.84% with the Loss of -0.25 points.
The shares of Fate Therapeutics, Inc. (NASDAQ:FATE) traded with the day volume of 870341 shares whereas its average trading volume is 831.07 Million.
While analyzing the past performance of the stock we can see that the shares of Fate Therapeutics, Inc. (NASDAQ:FATE) Loss -5.16% in the last week while rising 61.23% in the last month. Past quarter performance shows the green light with 211.69%. The semi-annual and annual performance shows 216.99% and 172.08% respectively.
Some critical values of the shares of Fate Therapeutics, Inc. (NASDAQ:FATE) to be discussed here are: the beta which shows the value at 1.66 while Average True Range of Fate Therapeutics, Inc. (NASDAQ:FATE) demonstrate the value at 1.05. The weekly and monthly volatility of the shares of Fate Therapeutics, Inc. (NASDAQ:FATE) are indicated at 8.13% and 9.80%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 68.16.
While studying the financial position of the shares of Fate Therapeutics, Inc. (NASDAQ:FATE), we can see that the Market capitalization of the company is at 648.69 Million. The shares outstanding for the company is 49.67 Million and the shares float stands at 49.67 Million. The income of the company stand at -43000000 while the sales stand at 4.1 Million.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -1.02, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 158.22, the Return on Asset ROA stood at -0.509 and the Return on Equity ROE depicted at -0.71 while Return on Investment ROI is at -0.459.
Imperva Inc. (NASDAQ:IMPV)
Imperva Inc. (NASDAQ:IMPV) started its previous trading session at $46.9 and closed at $46.5 showing a Fell of -0.75 Percent.
The Company traded with an average Volume of 392.92 Million whereas, its Day Volume stood at 689318.
Looking at the performance of the stock, Imperva Inc. (NASDAQ:IMPV) Loss -1.9% in the last week in its shares price and 10.58% in the last month. Quarterly performance shows a green of 13 Percent while Semi-Annual and Annual performances shows a 2.99 and 9.03 percent respectively.
Beta for Imperva Inc. (NASDAQ:IMPV) stands at 1.64 while the ATR (average true range) is at 1.54. The Stock’s Weekly and Monthly Volatility is 3.65% and 3.39% respectively showing a RSI value of 52.04.
While studying the financial position of the shares of Imperva Inc. (NASDAQ:IMPV), we can see that the Market capitalization of the company is at 1.6 Billion. The shares outstanding for the company is 34.45 Million and the shares float stands at 33.53 Million.
The Company generated an income of 22.7 Million and the sales of 321.7 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $0.67 a share. P/E (price to earnings) and P/S (price to sales) values are 69.61 and 4.98 respectively.
The Return on Assets stands at 0.046, ROE shows a value of 0.078 and ROI for Imperva Inc. (NASDAQ:IMPV) is -0.046 as of Trailing Twelve Months period.
